Proteomic analysis of saliva: a unique tool to distinguish primary Sjögren's syndrome from secondary Sjögren's syndrome and other sicca syndromes
Authors:
- Chiara BaldiniCBChiara Baldini
- Laura GiustiLGLaura Giusti
- Federica CiregiaFCFederica Ciregia
- Ylenia Da ValleYVYlenia Da Valle
- Camillo GiacomelliCGCamillo Giacomelli
- Elena DonadioEDElena Donadio
- Francesca SernissiFSFrancesca Sernissi
- Laura BazzichiLBLaura Bazzichi
- Gino GiannacciniGGGino Giannaccini
- Stefano BombardieriSBStefano Bombardieri
- Antonio LucacchiniALAntonio Lucacchini
Open Access
- 25 November 2011
- journal article
- Published by Springer Nature in Arthritis Research & Therapy
- Vol. 13 (6) , R194
Abstract
Introduction: A growing interest has arisen in salivary proteomics as a tool for the identification of biomarkers for primary Sjögren's syndrome (pSS). Nonetheless, only a limited number of preclinical validation studies have been performed, limiting the possibility of translating proteomic results into clinical practice. The primary aim of this study was to refine the diagnostic power of a panel of candidate salivary biomarkers described in pSS with respect to both healthy volunteers and pathological controls. We also explored the pathogenetic function of the detected putative biomarkers both in the local exocrinopathy and in the systemic inflammatory processes of SS. Methods: One hundred and eighty patients were included in the study overall. In the first "exploratory phase", we enrolled 40 females with pSS, 40 sex- and age-matched healthy volunteers, 10 patients with sicca non-SS and 15 secondary SS (sSS) patients. The testing cohort of the second "challenge phase" of the study was represented by 75 unselected, consecutive subjects: 19 pSS, 21 healthy volunteers, 10 sicca non-SS and 25 sSS patients. Salivary proteomic analysis was performed combining two-dimensional electrophoresis (2DE) and matrix-assisted laser desorption/ionisation time-of-flight mass spectrometry (MALDI-TOF-MS). Western blot (WB) analysis and enzyme-linked immunosorbent assay (ELISA) were employed to validate 2DE results. Ingenuity Pathway Analysis (IPA) Knowledge base was adopted to associate candidate biomarkers in a signalling pathogenetic network. Results: A total of 28, 6, 7 and 12 protein spots were found to be significantly different in pSS samples with respect to healthy volunteers, non-SS sicca syndrome, SSc-sSS and rheumatoid arthritis-sSS, leading to the identification of 15 differently expressed proteins. Among them, α-amylases precursor, carbonic anhydrase VI, β-2 microglobulin, glyceraldehydes-3-phosphate dehydrogenase (G3PDH), epidermal fatty acid binding protein (E-FABP) and immunoglobulin k light chain (IGK-light chain) apparently showed the most significant differences in pSS when compared to healthy volunteers and non-SS pathological controls. On the other hand, as expected, pSS and sSS salivary profiles shared a great number of similarities. Conclusions: This study demonstrated that salivary fluid might represent a novel ideal milieu for the detection of a diagnostic panel of candidate biomarkers for pSS, and to gain an insight into the pathogenetic processes underlying glandular and systemic autoimmune disorders.Keywords
This publication has 35 references indexed in Scilit:
- Mechanisms of Disease: primary Sjögren's syndrome and the type I interferon systemNature Clinical Practice Rheumatology, 2006
- Correlation of serum B lymphocyte stimulator and β2 microglobulin with autoantibody secretion and systemic involvement in primary Sjögren's syndromeAnnals of the Rheumatic Diseases, 2005
- Blue silver: A very sensitive colloidal Coomassie G‐250 staining for proteome analysisElectrophoresis, 2004
- A Statistical Model for Identifying Proteins by Tandem Mass SpectrometryAnalytical Chemistry, 2003
- Empirical Statistical Model To Estimate the Accuracy of Peptide Identifications Made by MS/MS and Database SearchAnalytical Chemistry, 2002
- Classification criteria for Sjögren's syndrome: a revised version of the European criteria proposed by the American-European Consensus GroupAnnals of the Rheumatic Diseases, 2002
- A modified silver staining protocol for visualization of proteins compatible with matrix-assisted laser desorption/ionization and electrospray ionization- mass spectrometryElectrophoresis, 2000
- Probability-based protein identification by searching sequence databases using mass spectrometry dataElectrophoresis, 1999
- Development of polyacrylamide gels that improve the separation of proteins and their detection by silver stainingAnalytical Biochemistry, 1988
- Salivary gland immunoglobulin and rheumatoid factor synthesis in Sjögren's syndromeThe American Journal of Medicine, 1972